Organization
Otsuka America Pharmaceutical, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Otsuka America Pharmaceutical, Inc.
... over the past two years by the maker of the drug, Otsuka America Pharmaceutical Inc., including for speeches about Rexulti, according to the federal Open ...
... profiled in this Schizophrenia Drugs statistical surveying incorporate are Johnson & Johnson, Otsuka Pharmaceuticals, AstraZeneca, Eli Lilly, Alkermes, Sumitomo Dainippon Pharma, Pfizer, Vanda Pharmaceuticals and ...
... Disease Specialty Pharmacy®, announced that it has been selected by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute JYNARQUE(TM) (tolvaptan),the only FDA-approved therapy for patients diagnosed ...
... Avellaannounced that it has been selected by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute JYNARQUE(TM) (tolvaptan),thevery firstFDA-approved therapy for patients diagnosed with ...
... guide PKD patients to the JYNARQUE(TM) clinical trials. JYNARQUE(TM) was developed by Otsuka Pharmaceuticals. PKD, a chronic, genetic disease, is characterized by uncontrolled growth of ...
... breastfeed during treatment with JYNARQUE. To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at1-800-438-9927or FDA at1-800-FDA-1088( www.fda.gov/medwatch ). Please see FULL PRESCRIBING INFORMATION ...
... In celebration of the vibrant startup community in Austin, TX, Otsuka America Pharmaceutical, Inc. (Otsuka) brought together innovators and startups in a live Pitch Event ...
... based pharma executive,Ed Stelmakhserves as the Vice President and CFO at Otsuka America Pharmaceutical, Inc. Serving a one-year term, beginning January 1, the new AFSP ...
... Food and Drug Administration (US FDA) to market generic version of Otsuka America Pharmaceutical Inc.'s Dacogen. Cipla's Decitabine Injection 50 mg/vial is AP-rated and is ...
... with the previously announced keynoters, Andrew Wright, Vice President, Digital Medicine, OTSUKA America Pharmaceutical, Inc. and James Schuster, MD, MBA, Chief Medical Officer & Vice ...
Subscribe now for full coverage on Otsuka America Pharmaceutical, Inc.
Start My Free Trial